Analyzing Safeguard Scientifics (SFE) and Its Rivals
Safeguard Scientifics (NYSE: SFE) is one of 55 public companies in the “Investment Management & Fund Operators” industry, but how does it weigh in compared to its rivals? We will compare Safeguard Scientifics to related companies based on the strength of its dividends, valuation, risk, institutional ownership, analyst recommendations, profitability and earnings.
This table compares Safeguard Scientifics and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Safeguard Scientifics Competitors||-44.72%||7.65%||5.15%|
Volatility and Risk
Safeguard Scientifics has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Safeguard Scientifics’ rivals have a beta of 1.23, suggesting that their average stock price is 23% more volatile than the S&P 500.
This is a breakdown of current ratings and recommmendations for Safeguard Scientifics and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Safeguard Scientifics Competitors||358||1793||1816||63||2.39|
As a group, “Investment Management & Fund Operators” companies have a potential upside of 7.63%. Given Safeguard Scientifics’ rivals higher possible upside, analysts clearly believe Safeguard Scientifics has less favorable growth aspects than its rivals.
Insider and Institutional Ownership
77.6% of Safeguard Scientifics shares are owned by institutional investors. Comparatively, 62.1% of shares of all “Investment Management & Fund Operators” companies are owned by institutional investors. 2.7% of Safeguard Scientifics shares are owned by insiders. Comparatively, 10.5% of shares of all “Investment Management & Fund Operators” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Safeguard Scientifics and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Safeguard Scientifics||N/A||-$17.72 million||-2.83|
|Safeguard Scientifics Competitors||$2.88 billion||$924.32 million||7.13|
Safeguard Scientifics’ rivals have higher revenue and earnings than Safeguard Scientifics. Safeguard Scientifics is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Safeguard Scientifics rivals beat Safeguard Scientifics on 6 of the 9 factors compared.
About Safeguard Scientifics
Safeguard Scientifics, Inc. is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies. The Company offers operational and management support to each of its partner companies. In addition to management and operational support, the Company offers ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management. The Company serves on the boards of directors of its partner companies, working with them to develop and implement strategic and operating plans. It measures and monitors achievement of these plans through regular review of operational and financial performance measurements.
Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.